🆓 Free Public Citation & Sample Record #1 (clinical-trials.withsilex.com)
Recently updated NIH study NCT05966961 (RECRUITING): Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery
{
"nct_id": "NCT05966961",
"title": "Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery",
"status": "RECRUITING",
"phase": "OBSERVATIONAL",
"conditions": "Surgical Site Infection",
"verify_url": "https://clinicaltrials.gov/study/NCT05966961"
}
🔓 UNLOCKED WHOLE KEYWORD LIBRARY (5 DATASETS)
{"id":"pulse_clinical-trials_20261118-1400","url":"https://clinical-trials.withsilex.com/v1/pulse/pulse-20261118-1400","domain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","sha256":"14050ba8a4a6c30092f541f961ea2a6127c0b2bf731fe570c4fdf65afb574b10","data":{"protocol":"WithSilex-x402/1.4.0","handle":"clinical-trials","fqdn":"clinical-trials.withsilex.com","slot_utc":"2026-11-18T14:00:52.922Z","title":"Phase-III Primary Endpoint & Biomarker Deltas","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","license":"US-Gov-Public-Domain-17USC105","what_happened":"Recently updated NIH study NCT05966961 (RECRUITING): Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery","executive_summary":"Recently updated NIH study NCT05966961 (RECRUITING): Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery","delta_since_last_slot":"+6 new primary record(s) since prior slot (NCT05966961, NCT07881159, NCT05276973)","delta_changed_count":6,"related_synthesis":{"nexusId":"biomed-fda-grants","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants"},"record_count":6,"records":[{"nct_id":"NCT05966961","title":"Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Surgical Site Infection","verify_url":"https://clinicaltrials.gov/study/NCT05966961"},{"nct_id":"NCT07881159","title":"National Registry of Noonan Syndrome","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Noonan Syndrome","verify_url":"https://clinicaltrials.gov/study/NCT07881159"},{"nct_id":"NCT05276973","title":"Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ova","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE1","conditions":"Fallopian Tube Endometrioid Adenocarcinoma; Fallopian Tube High Grade Serous Adenocarcinoma; Ovarian Endometrioid Adenocarcinoma","verify_url":"https://clinicaltrials.gov/study/NCT05276973"},{"nct_id":"NCT04885569","title":"Culturally Adapted Motivational Interviewing With CBT and Mindfulness Based Relapse Prevention for Substance Use Disorder in Pakistan (","status":"COMPLETED","phase":"NA","conditions":"Substance Use Disorder (SUD)","verify_url":"https://clinicaltrials.gov/study/NCT04885569"},{"nct_id":"NCT00001403","title":"Study of Proteus Syndrome and Related Congenital Disorders","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Proteus Syndrome; PIK3CA Related Overgrowth Spectrum","verify_url":"https://clinicaltrials.gov/study/NCT00001403"},{"nct_id":"NCT07936539","title":"Effects of a Digital Game-Based Educational Intervention on Midwifery Students' Perceptions of Respectful Maternity Care and Empathy","status":"NOT_YET_RECRUITING","phase":"NA","conditions":"Respectful Maternity Care; Empathy; Midwifery","verify_url":"https://clinicaltrials.gov/study/NCT07936539"}],"signal_sha256":"14050ba8a4a6c30092f541f961ea2a6127c0b2bf731fe570c4fdf65afb574b10"}}
{"id":"synth_biomed-fda-grants_20261118-1415","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261118-1415","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"56dfd982f1d90d1cb040df105a860cbf1ba4d46a8e540b974f72f713bce498f1","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-18T14:15:48.971Z","slot_compact":"20261118-1415","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT05966961 (RECRUITING): Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective... | [cold-chain] Recent FDA enforcement action H-0197-2027 (Class I) by Family Farmstead Dairy, LLC: Potential contamination with E. coli (pathogenic non-O157...","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT05966961 (RECRUITING): Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery","top_records":[{"nct_id":"NCT05966961","title":"Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Surgical Site Infection","verify_url":"https://clinicaltrials.gov/study/NCT05966961"},{"nct_id":"NCT07881159","title":"National Registry of Noonan Syndrome","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Noonan Syndrome","verify_url":"https://clinicaltrials.gov/study/NCT07881159"},{"nct_id":"NCT05276973","title":"Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ova","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE1","conditions":"Fallopian Tube Endometrioid Adenocarcinoma; Fallopian Tube High Grade Serous Adenocarcinoma; Ovarian Endometrioid Adenocarcinoma","verify_url":"https://clinicaltrials.gov/study/NCT05276973"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0197-2027 (Class I) by Family Farmstead Dairy, LLC: Potential contamination with E. coli (pathogenic non-O157 STEC).","top_records":[{"recall_number":"H-0197-2027","firm":"Family Farmstead Dairy, LLC","classification":"Class I","location":"Worcester, NY","report_date":"20261111","reason":"Potential contamination with E. coli (pathogenic non-O157 STEC)."},{"recall_number":"H-0192-2027","firm":"Krasnyi Oktyabr Inc","classification":"Class I","location":"Brooklyn, NY","report_date":"20261111","reason":"Contaminated with Listeria monocytogenes"},{"recall_number":"H-0191-2027","firm":"Krasnyi Oktyabr Inc","classification":"Class I","location":"Brooklyn, NY","report_date":"20261111","reason":"Contaminated with Listeria monocytogenes"}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"67877-429","generic_name":"Gabapentin","brand_name":"Gabapentin","dosage_form":"TABLET","labeler":"Ascend Laboratories, LLC","marketing_category":"ANDA"},{"product_ndc":"67414-226","generic_name":"DIPHENHYDRAMINE HYDROCHLORIDE","brand_name":"Benadryl Allergy Ultratab","dosage_form":"TABLET, FILM COATED","labeler":"Jones Healthcare Group - Packaging Services, Inc","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"67711-001","generic_name":"OXYGEN","brand_name":"OXYGEN","dosage_form":"GAS","labeler":"AIRSERVE, LLC","marketing_category":"UNAPPROVED MEDICAL GAS"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"7K01AA029712-06","principal_investigator":"GRODIN, ERICA N","institution":"ARIZONA STATE UNIVERSITY-TEMPE CAMPUS","award_usd":100038,"title":"Characterizing the Microbiome-Gut-Brain Axis in Individuals with Alcohol Use Disorder","reporter_url":"https://reporter.nih.gov/project-details/11647352"},{"grant_id":"5P20GM139733-04","principal_investigator":"ZHANG, E (ALICE) ","institution":"UNIVERSITY OF KANSAS MEDICAL CENTER","award_usd":232500,"title":"Advancing OASIS Parent Training Toward Real-World Effectiveness in Community ABA Agencies","reporter_url":"https://reporter.nih.gov/project-details/11694438"}]}],"signal_sha256":"56dfd982f1d90d1cb040df105a860cbf1ba4d46a8e540b974f72f713bce498f1"}}
{"id":"synth_biomed-fda-grants_20261118-1430","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261118-1430","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"ec41c222eea9864e34379bd1b5743004a129d3e738dacd44d0e96182494c2c46","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-18T14:30:44.857Z","slot_compact":"20261118-1430","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT05966961 (RECRUITING): Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective... | [cold-chain] Recent FDA enforcement action H-0197-2027 (Class I) by Family Farmstead Dairy, LLC: Potential contamination with E. coli (pathogenic non-O157...","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT05966961 (RECRUITING): Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery","top_records":[{"nct_id":"NCT05966961","title":"Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Surgical Site Infection","verify_url":"https://clinicaltrials.gov/study/NCT05966961"},{"nct_id":"NCT07881159","title":"National Registry of Noonan Syndrome","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Noonan Syndrome","verify_url":"https://clinicaltrials.gov/study/NCT07881159"},{"nct_id":"NCT05276973","title":"Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ova","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE1","conditions":"Fallopian Tube Endometrioid Adenocarcinoma; Fallopian Tube High Grade Serous Adenocarcinoma; Ovarian Endometrioid Adenocarcinoma","verify_url":"https://clinicaltrials.gov/study/NCT05276973"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0197-2027 (Class I) by Family Farmstead Dairy, LLC: Potential contamination with E. coli (pathogenic non-O157 STEC).","top_records":[{"recall_number":"H-0197-2027","firm":"Family Farmstead Dairy, LLC","classification":"Class I","location":"Worcester, NY","report_date":"20261111","reason":"Potential contamination with E. coli (pathogenic non-O157 STEC)."},{"recall_number":"H-0192-2027","firm":"Krasnyi Oktyabr Inc","classification":"Class I","location":"Brooklyn, NY","report_date":"20261111","reason":"Contaminated with Listeria monocytogenes"},{"recall_number":"H-0191-2027","firm":"Krasnyi Oktyabr Inc","classification":"Class I","location":"Brooklyn, NY","report_date":"20261111","reason":"Contaminated with Listeria monocytogenes"}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"67877-429","generic_name":"Gabapentin","brand_name":"Gabapentin","dosage_form":"TABLET","labeler":"Ascend Laboratories, LLC","marketing_category":"ANDA"},{"product_ndc":"67414-226","generic_name":"DIPHENHYDRAMINE HYDROCHLORIDE","brand_name":"Benadryl Allergy Ultratab","dosage_form":"TABLET, FILM COATED","labeler":"Jones Healthcare Group - Packaging Services, Inc","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"67711-001","generic_name":"OXYGEN","brand_name":"OXYGEN","dosage_form":"GAS","labeler":"AIRSERVE, LLC","marketing_category":"UNAPPROVED MEDICAL GAS"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"7K01AA029712-06","principal_investigator":"GRODIN, ERICA N","institution":"ARIZONA STATE UNIVERSITY-TEMPE CAMPUS","award_usd":100038,"title":"Characterizing the Microbiome-Gut-Brain Axis in Individuals with Alcohol Use Disorder","reporter_url":"https://reporter.nih.gov/project-details/11647352"},{"grant_id":"5P20GM139733-04","principal_investigator":"ZHANG, E (ALICE) ","institution":"UNIVERSITY OF KANSAS MEDICAL CENTER","award_usd":232500,"title":"Advancing OASIS Parent Training Toward Real-World Effectiveness in Community ABA Agencies","reporter_url":"https://reporter.nih.gov/project-details/11694438"}]}],"signal_sha256":"ec41c222eea9864e34379bd1b5743004a129d3e738dacd44d0e96182494c2c46"}}
{"id":"synth_biomed-fda-grants_20261118-1400","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261118-1400","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"2be88ec5490411bb86b294e31ae0c62edf801d8247fe2f32bd68aae829c011c7","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-18T14:00:52.922Z","slot_compact":"20261118-1400","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT05966961 (RECRUITING): Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective... | [cold-chain] Recent FDA enforcement action H-0197-2027 (Class I) by Family Farmstead Dairy, LLC: Potential contamination with E. coli (pathogenic non-O157...","delta_since_last_slot":"clinical-trials: +6 new primary record(s) since prior slot (NCT05966961, NCT078811 · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: Verified unchanged vs prior 15m check (6 active records confirmed · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"+6 new primary record(s) since prior slot (NCT05966961, NCT07881159, NCT05276973)","what_happened":"Recently updated NIH study NCT05966961 (RECRUITING): Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery","top_records":[{"nct_id":"NCT05966961","title":"Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Surgical Site Infection","verify_url":"https://clinicaltrials.gov/study/NCT05966961"},{"nct_id":"NCT07881159","title":"National Registry of Noonan Syndrome","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Noonan Syndrome","verify_url":"https://clinicaltrials.gov/study/NCT07881159"},{"nct_id":"NCT05276973","title":"Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ova","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE1","conditions":"Fallopian Tube Endometrioid Adenocarcinoma; Fallopian Tube High Grade Serous Adenocarcinoma; Ovarian Endometrioid Adenocarcinoma","verify_url":"https://clinicaltrials.gov/study/NCT05276973"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0197-2027 (Class I) by Family Farmstead Dairy, LLC: Potential contamination with E. coli (pathogenic non-O157 STEC).","top_records":[{"recall_number":"H-0197-2027","firm":"Family Farmstead Dairy, LLC","classification":"Class I","location":"Worcester, NY","report_date":"20261111","reason":"Potential contamination with E. coli (pathogenic non-O157 STEC)."},{"recall_number":"H-0192-2027","firm":"Krasnyi Oktyabr Inc","classification":"Class I","location":"Brooklyn, NY","report_date":"20261111","reason":"Contaminated with Listeria monocytogenes"},{"recall_number":"H-0191-2027","firm":"Krasnyi Oktyabr Inc","classification":"Class I","location":"Brooklyn, NY","report_date":"20261111","reason":"Contaminated with Listeria monocytogenes"}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"67877-429","generic_name":"Gabapentin","brand_name":"Gabapentin","dosage_form":"TABLET","labeler":"Ascend Laboratories, LLC","marketing_category":"ANDA"},{"product_ndc":"67414-226","generic_name":"DIPHENHYDRAMINE HYDROCHLORIDE","brand_name":"Benadryl Allergy Ultratab","dosage_form":"TABLET, FILM COATED","labeler":"Jones Healthcare Group - Packaging Services, Inc","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"67711-001","generic_name":"OXYGEN","brand_name":"OXYGEN","dosage_form":"GAS","labeler":"AIRSERVE, LLC","marketing_category":"UNAPPROVED MEDICAL GAS"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"7K01AA029712-06","principal_investigator":"GRODIN, ERICA N","institution":"ARIZONA STATE UNIVERSITY-TEMPE CAMPUS","award_usd":100038,"title":"Characterizing the Microbiome-Gut-Brain Axis in Individuals with Alcohol Use Disorder","reporter_url":"https://reporter.nih.gov/project-details/11647352"},{"grant_id":"5P20GM139733-04","principal_investigator":"ZHANG, E (ALICE) ","institution":"UNIVERSITY OF KANSAS MEDICAL CENTER","award_usd":232500,"title":"Advancing OASIS Parent Training Toward Real-World Effectiveness in Community ABA Agencies","reporter_url":"https://reporter.nih.gov/project-details/11694438"}]}],"signal_sha256":"2be88ec5490411bb86b294e31ae0c62edf801d8247fe2f32bd68aae829c011c7"}}
{"id":"synth_biomed-fda-grants_20261118-1445","url":"https://dispatch.withsilex.com/synthesis/biomed-fda-grants?slot=20261118-1445","domain":"dispatch.withsilex.com","source":"Multi-Subdomain Correlated Synthesis","sha256":"427883fb7d3eb734b463939de8c40e53970f6eb8ac9f9ed68efe7ce0f5552fff","data":{"protocol":"WithSilex-x402-Synthesis/1.4.0","nexus_id":"biomed-fda-grants","slot_utc":"2026-11-18T14:45:52.829Z","slot_compact":"20261118-1445","title":"NIH Clinical Pipeline, FDA Recall Enforcement & Grant Capital Nexus","participating_subdomains":["https://clinical-trials.withsilex.com/","https://cold-chain.withsilex.com/","https://icd-formulary.withsilex.com/","https://orcid-graph.withsilex.com/"],"what_happened":"Cross-Domain Synthesis (clinical-trials × cold-chain × icd-formulary × orcid-graph): [clinical-trials] Recently updated NIH study NCT05966961 (RECRUITING): Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective... | [cold-chain] Recent FDA enforcement action H-0197-2027 (Class I) by Family Farmstead Dairy, LLC: Potential contamination with E. coli (pathogenic non-O157...","delta_since_last_slot":"clinical-trials: Verified unchanged vs prior 15m check (6 active records confirmed · cold-chain: Verified unchanged vs prior 15m check (5 active records confirmed · icd-formulary: +6 new primary record(s) since prior slot (76125-661, 76176-134, · orcid-graph: Verified unchanged vs prior 15m check (5 active records confirmed","correlated_stream_count":4,"records":[{"subdomain":"clinical-trials.withsilex.com","source":"NIH ClinicalTrials.gov v2 Registry API (clinicaltrials.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (6 active records confirmed).","what_happened":"Recently updated NIH study NCT05966961 (RECRUITING): Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery","top_records":[{"nct_id":"NCT05966961","title":"Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds After Emergency or Elective Laparotomy or Laparoscopic Surgery","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Surgical Site Infection","verify_url":"https://clinicaltrials.gov/study/NCT05966961"},{"nct_id":"NCT07881159","title":"National Registry of Noonan Syndrome","status":"RECRUITING","phase":"OBSERVATIONAL","conditions":"Noonan Syndrome","verify_url":"https://clinicaltrials.gov/study/NCT07881159"},{"nct_id":"NCT05276973","title":"Testing the Addition of Ipatasertib to the Usual Chemotherapy Treatment (Paclitaxel and Carboplatin) for Stage III or IV Epithelial Ova","status":"ACTIVE_NOT_RECRUITING","phase":"PHASE1","conditions":"Fallopian Tube Endometrioid Adenocarcinoma; Fallopian Tube High Grade Serous Adenocarcinoma; Ovarian Endometrioid Adenocarcinoma","verify_url":"https://clinicaltrials.gov/study/NCT05276973"}]},{"subdomain":"cold-chain.withsilex.com","source":"U.S. FDA openFDA Enforcement Reports API (api.fda.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Recent FDA enforcement action H-0197-2027 (Class I) by Family Farmstead Dairy, LLC: Potential contamination with E. coli (pathogenic non-O157 STEC).","top_records":[{"recall_number":"H-0197-2027","firm":"Family Farmstead Dairy, LLC","classification":"Class I","location":"Worcester, NY","report_date":"20261111","reason":"Potential contamination with E. coli (pathogenic non-O157 STEC)."},{"recall_number":"H-0192-2027","firm":"Krasnyi Oktyabr Inc","classification":"Class I","location":"Brooklyn, NY","report_date":"20261111","reason":"Contaminated with Listeria monocytogenes"},{"recall_number":"H-0191-2027","firm":"Krasnyi Oktyabr Inc","classification":"Class I","location":"Brooklyn, NY","report_date":"20261111","reason":"Contaminated with Listeria monocytogenes"}]},{"subdomain":"icd-formulary.withsilex.com","source":"U.S. FDA National Drug Code (NDC) Directory API (api.fda.gov)","delta_since_last_slot":"+6 new primary record(s) since prior slot (76125-661, 76176-134, 76282-768)","what_happened":"Active FDA-registered National Drug Code (NDC) formulary entries, dosage forms, and marketing categories.","top_records":[{"product_ndc":"76125-661","generic_name":"Antihemophilic Factor (Human)","brand_name":"Koate","dosage_form":"KIT","labeler":"KEDRION BIOPHARMA, INC.","marketing_category":"BLA"},{"product_ndc":"76176-134","generic_name":"Pyrithione Zinc","brand_name":"ITCHY SCALP RELIEF DANDRUFF","dosage_form":"SHAMPOO","labeler":"NINGBO LIYUAN DAILY CHEMICAL PRODUCTS CO., LTD.","marketing_category":"OTC MONOGRAPH DRUG"},{"product_ndc":"76282-768","generic_name":"Paclitaxel protein-bound particles","brand_name":"Paclitaxel 100mg per vial","dosage_form":"INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION","labeler":"EXELAN PHARMACEUTICALS INC.","marketing_category":"ANDA"}]},{"subdomain":"orcid-graph.withsilex.com","source":"NIH RePORTER v2 Federal Research Grants API (api.reporter.nih.gov)","delta_since_last_slot":"Verified unchanged vs prior 15m check (5 active records confirmed).","what_happened":"Active federal research grant 1F31AG099736-01 at MEDICAL UNIVERSITY OF SOUTH CAROLINA (PI: CUTTY, MAXWELL ).","top_records":[{"grant_id":"1F31AG099736-01","principal_investigator":"CUTTY, MAXWELL ","institution":"MEDICAL UNIVERSITY OF SOUTH CAROLINA","award_usd":45938,"title":"Evaluating the Contribution of Care Pathways and Clinical Features To Home Health Quality Outcomes for People with Dementia","reporter_url":"https://reporter.nih.gov/project-details/11318525"},{"grant_id":"7K01AA029712-06","principal_investigator":"GRODIN, ERICA N","institution":"ARIZONA STATE UNIVERSITY-TEMPE CAMPUS","award_usd":100038,"title":"Characterizing the Microbiome-Gut-Brain Axis in Individuals with Alcohol Use Disorder","reporter_url":"https://reporter.nih.gov/project-details/11647352"},{"grant_id":"5P20GM139733-04","principal_investigator":"ZHANG, E (ALICE) ","institution":"UNIVERSITY OF KANSAS MEDICAL CENTER","award_usd":232500,"title":"Advancing OASIS Parent Training Toward Real-World Effectiveness in Community ABA Agencies","reporter_url":"https://reporter.nih.gov/project-details/11694438"}]}],"signal_sha256":"427883fb7d3eb734b463939de8c40e53970f6eb8ac9f9ed68efe7ce0f5552fff"}}
clinical-trials.withsilex.com · 2026-11-18 14:00 UTC · Recently updated NIH study NCT05966961 (RECRUITING): Novosyn® CHD vs Polyglactin 910 Suture to Close Wounds Af